Rebecca A. Law

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

Allelic frequencies of the hs1.2 enhancer within the immunoglobulin heavy chain region in Dayton, Ohio patients screened for celiac disease with duodenal biopsy.

Paul G. Koles, M. Bottomley, C. Sulentic, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis

Lisa C. Brown, D. Müller, Lisa C Brown, 2022, The Pharmacogenomics Journal.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2021, The Lancet.

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Nguyen H. Tran, Andreas C. Themistocleous, David J. Smith, 2020, Lancet.

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

R. Shelton, M. Thase, B. Dunlop, 2020, Psychiatry Research.

Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder

R. Shelton, M. Thase, B. Dunlop, 2020, Psychiatry Research.

Single nucleotide polymorphisms in C-reactive protein (CRP) predict response to adjunctive celecoxib treatment of resistant bipolar depression

A. Halaris, M. Filip, Rebecca A. Law, 2023, Brain, behavior, & immunity - health.

Review and Meta-analysis on the Impact of the ADRA2A Variant rs1800544 on Methylphenidate Outcomes in Attention-Deficit/Hyperactivity Disorder

Elizabeth S. Cogan, Rebecca A. Law, Talal Al Habbab, 2021, Biological psychiatry global open science.

Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using in vitro models of hepatic metabolism

M. DelBello, J. Frazier, J. Lanchbury, 2022, Xenobiotica; the fate of foreign compounds in biological systems.

Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder

R. Shelton, M. Thase, B. Dunlop, 2021, Psychiatry Research.